A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)

Clinical trial NCT00990821 · COMPLETED

Trial details

NCT number: NCT00990821
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting Postoperative Nausea and Vomiting

Start date: 2005-01-01
Primary completion: 2005-12-01
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.